Glycosylation can significantly affect the performance, consistency and cost of your biopharmaceutical. Read more

Welcome to Ludger

The team of specialists at Ludger can provide glycan analysis services and technology to help you engineer, optimise, measure and control the glycosylation of your therapeutic glycoprotein product. Ludger products have been developed and validated to provide reliable sample preparation. Established in 1999 we have a wealth of experience providing structural glycan characterisation of innovator and biosimilar biotherapeutics, including:

  • Monoclonal antibodies (mAbs)
  • Hormones e.g erythropoeitin (EPO)
  • Fc fusion proteins
  • Plant glycoproteins
  • Viral glycoproteins
  • Parasitic glycoproteins
  • Vaccines
  • Clotting factors

This will help you address safety, efficacy, product consistency, stability and half-life, regulatory compliance, patent issues and comparability of your drugs. Analytical methods used in house include (U)HPLC, ESI-MS, MALDI-MS, LC-MS. In addition we can work to Good Manufacturing Practice (GMP) level services for our clients

Join our mailing list

´╗┐Complete the form below to subscribe to our email newsletter